The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).

The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).

Olulade Ayodele,1 Howard J Cabral,2,3 David McManus,4 Susan Jick1,5 1Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA; 2Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; 3Biostatistics and Research Design Program, Boston Un...

Full description

Bibliographic Details
Main Authors: Ayodele O, Cabral HJ, McManus D, Jick S
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Clinical Epidemiology
Subjects:
5ari
bph
vte
alpha blocker
Online Access:https://www.dovepress.com/the-risk-of-venous-thromboembolism-vte-in-men-with-benign-prostatic-hy-peer-reviewed-fulltext-article-CLEP

Internet

https://www.dovepress.com/the-risk-of-venous-thromboembolism-vte-in-men-with-benign-prostatic-hy-peer-reviewed-fulltext-article-CLEP

Similar Items